Sepsis y shock séptico

  1. D. Micheloud Giménez 1
  2. E. Gargallo García 1
  3. D. Sánchez Sendín 1
  1. 1 Hospital General Universitario Gregorio Marañón
    info

    Hospital General Universitario Gregorio Marañón

    Madrid, España

    ROR https://ror.org/0111es613

Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2015

Título del ejemplar: Urgencias (IV): Urgencias digestivas. Crisis hipertensiva. Shock. Alteraciones iónicas

Serie: 11

Número: 90

Páginas: 5365-5370

Tipo: Artículo

DOI: 10.1016/J.MED.2015.11.002 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

La sepsis representa un problema sanitario grave, con alta morbimortalidad. Su evolución natural puede modificarse cuando se realiza un diagnóstico rápido y se comienza con las medidas de tratamiento de forma inmediata. El retraso en el tratamiento condiciona una alta mortalidad. Es preciso iniciar la hidratación parenteral inmediata, así como el tratamiento antibiótico empírico con sospecha de foco o sin ella posterior a la toma de hemocultivos y cultivo de otros focos según el caso. Las guías y consensos orientan en líneas generales, aunque inciden en la necesidad de un tratamiento individualizado a cada paciente.

Referencias bibliográficas

  • Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of in-novative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest. 2009;136(5 Suppl):e28.
  • Badia M, Iglesias S, Servia L, Domingo J, Gormaz P, Vilanova J, et al. Mortality predictive factors in patients with urinary sepsis associated to upper urinary tract calculi. Med Intensiva. 2015;39(5):290-7.
  • Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38(2):367-74.
  • Baghel K, Srivastava RN, Chandra A, Goel SK, Agrawal J, Kazmi HR, et al. TNF-alpha, IL-6, and IL-8 cytokines and their association with TNF-alpha-308 G/A polymorphism and postoperative sepsis. J Gastrointest Surg. 2014;18(8):1486-94.
  • Bouza C, López-Cuadrado T, Saz-Parkinson Z, Amate-Blanco JM. Epi-demiology and recent trends of severe sepsis in Spain: a nationwide po-pulation-based analysis (2006-2011). BMC infectious diseases. 2014;14: 3863.
  • Bakker J, Perner A, Timsit JF. Evaluation of 7.5 years of Surviving Sepsis Campaign Guidelines. Intensive care medicine. 2015;41(1):151-3. Epub 2014/10/30. Guías Internacionales.
  • Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lym-phocytes. Nature. 1996;383(6603):787-93.
  • Liaw PC, Esmon CT, Kahnamoui K, Schmidt S, Kahnamoui S, Ferrell G, et al. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood. 2004;104(13):3958-64.
  • Li B, Li J, Pan X, Ding G, Cao H, Jiang W, et al. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation. Int Immunopharmacol. 2010;10(3):344-50.
  • Howell MD, Talmor D, Schuetz P, Hunziker S, Jones AE, Shapiro NI. Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39(2):322-7.
  • Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care. 2008;12(6):R161.
  • Murray PR, Masur H. Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit. Critical care medicine. 2012;40(12):3277-82.
  • Murray V, Huang Y, Chen J, Wang J, Li Q. A novel bacterial expression method with optimized parameters for very high yield production of triple-labeled proteins. Methods Mol Biol. 2012;831:1-18.
  • Dark P, Wilson C, Blackwood B, McAuley DF, Perkins GD, McMullan R, et al. Accuracy of LightCycler(R) SeptiFast for the detection and identi-fication of pathogens in the blood of patients with suspected sepsis: a systematic review protocol. BMJ open. 2012;2(1):e000392.
  • Moreno RP, Metnitz B, Adler L, Hoechtl A, Bauer P, Metnitz PG. Sepsis mortality prediction based on predisposition, infection and response. In-tensive Care Med. 2008;34(3):496-504.
  • Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England J Med. 2001;345(19):1368-77.
  • Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. Jama. 2010;303(8):739-46.
  • Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752-61.
  • De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepi-nephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med. 2012;40(3):725-30.
  • Russell JA. Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care. 2011;15(4):226.
  • Kellum JA, M Decker J. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 2001;29(8):1526-31.
  • Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gau-dio R, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. Jama. 2009;301(22):2362-75.
  • Sligl WI, Milner DA, Jr., Sundar S, Mphatswe W, Majumdar SR. Safety and efficacy of corticosteroids for the treatment of septic shock: A syste-matic review and meta-analysis. Clin Infect Dis. 2009;49(1):93-101.
  • Rello J, Pérez M, Roca O, Poulakou G, Souto J, Laborda C, et al. High-flow nasal therapy in adults with severe acute respiratory infection: a co-hort study in patients with 2009 influenza A/H1N1v. J Crit Care. 2012;27(5):434-9.
  • Masclans JR, Pérez M, Almirall J, Lorente L, Marques A, Socias L, et al. Early non-invasive ventilation treatment for severe influenza pneumonia. Clin Microbiol Infect. 2013;19(3):249-56.
  • Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. Jama. 2010;303(9):865-73.
  • Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recom-mendations for the transfusion of plasma and platelets. Blood Transfus. 2009;7(2):132-50.
  • Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. Jama. 2001;286(15):1869-78.
  • Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-con-trolled multicenter trial. Am J Respir Crit Care Med. 2009;180(7):640-8.
  • Elke G, Schadler D, Engel C, Bogatsch H, Frerichs I, Ragaller M, et al. Current practice in nutritional support and its association with mortality in septic patients--results from a national, prospective, multicenter study. Crit Care Med. 2008;36(6):1762-7.
Fuente de los datos: Dialnet